The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators.
暂无分享,去创建一个
[1] G M Kasof,et al. Livin, a Novel Inhibitor of Apoptosis Protein Family Member* , 2001, The Journal of Biological Chemistry.
[2] D. Maier,et al. Dynamic expression of Drosophila TRAF1 during embryogenesis and larval development , 2001, Mechanisms of Development.
[3] M. Eby,et al. The Ectodermal Dysplasia Receptor Activates the Nuclear Factor-κB, JNK, and Cell Death Pathways and Binds to Ectodysplasin A* , 2001, The Journal of Biological Chemistry.
[4] Zhong-Ping Feng,et al. Cross-talk between G-protein and Protein Kinase C Modulation of N-type Calcium Channels Is Dependent on the G-protein β Subunit Isoform* , 2000, The Journal of Biological Chemistry.
[5] S. Srinivasula,et al. Activation of the IκB Kinases by RIP via IKKγ/NEMO-mediated Oligomerization* , 2000, The Journal of Biological Chemistry.
[6] Hiroshi Takayanagi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.
[7] G. Salvesen,et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas , 2000, Current Biology.
[8] K. Matsumoto,et al. ASK1 Inhibits Interleukin-1-induced NF-κB Activity through Disruption of TRAF6-TAK1 Interaction* , 2000, The Journal of Biological Chemistry.
[9] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[10] Peter Jackson,et al. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. , 2000, Trends in cell biology.
[11] M. Fenton,et al. Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[12] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[13] J C Reed,et al. Molecular basis for CD40 signaling mediated by TRAF3. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Lucas,et al. An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways , 2000 .
[15] T. Hunter,et al. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. , 2000, The Journal of biological chemistry.
[16] D. Golenbock,et al. The biology of Toll-like receptors. , 2000, Cytokine & growth factor reviews.
[17] D. Goeddel,et al. T6BP, a TRAF6-interacting protein involved in IL-1 signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Scheurich,et al. Inhibition of Death Receptor-mediated Gene Induction by a Cycloheximide-sensitive Factor Occurs at the Level of or Upstream of Fas-associated Death Domain Protein (FADD)* , 2000, The Journal of Biological Chemistry.
[19] D. Goeddel,et al. MIP-T3, a Novel Protein Linking Tumor Necrosis Factor Receptor-associated Factor 3 to the Microtubule Network* , 2000, The Journal of Biological Chemistry.
[20] C. Thompson,et al. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. , 2000, The American journal of pathology.
[21] H. Wu,et al. Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Vidalain,et al. CD40 signaling in human dendritic cells is initiated within membrane rafts , 2000, The EMBO journal.
[23] J. Treanor,et al. Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation , 2000, The Journal of experimental medicine.
[24] Y. E. Chin,et al. Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.
[25] Young Chul Park,et al. A Novel Mechanism of TRAF Signaling Revealed by Structural and Functional Analyses of the TRADD–TRAF2 Interaction , 2000, Cell.
[26] K. Tyler,et al. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Vandenabeele,et al. TTRAP, a Novel Protein That Associates with CD40, Tumor Necrosis Factor (TNF) Receptor-75 and TNF Receptor-associated Factors (TRAFs), and That Inhibits Nuclear Factor-κB Activation* , 2000, The Journal of Biological Chemistry.
[28] D H Tsao,et al. Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway. , 2000, Molecular cell.
[29] F. Martinon,et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.
[30] G. Bishop,et al. Recruitment of CD40 and Tumor Necrosis Factor Receptor-associated Factors 2 and 3 to Membrane Microdomains during CD40 Signaling* , 2000, The Journal of Biological Chemistry.
[31] M. Eby,et al. TAJ, a Novel Member of the Tumor Necrosis Factor Receptor Family, Activates the c-Jun N-terminal Kinase Pathway and Mediates Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.
[32] G. Nemerow,et al. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] Yili Yang,et al. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. , 2000, Science.
[34] T. Honjo,et al. Alymphoplasia (aly)-Type Nuclear Factor κB–Inducing Kinase (Nik) Causes Defects in Secondary Lymphoid Tissue Chemokine Receptor Signaling and Homing of Peritoneal Cells to the Gut-Associated Lymphatic Tissue System , 2000, The Journal of experimental medicine.
[35] A. Godzik,et al. The Drosophila Tumor Necrosis Factor Receptor-associated Factor-1 (DTRAF1) Interacts with Pelle and Regulates NFκB Activity* , 2000, The Journal of Biological Chemistry.
[36] H. Shu,et al. Activation of NF-κB by FADD, Casper, and Caspase-8* , 2000, The Journal of Biological Chemistry.
[37] H. Nakano,et al. The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.
[38] K. Yamaguchi,et al. Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction , 2000, The Journal of experimental medicine.
[39] K. Irie,et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.
[40] M. Kelliher,et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.
[41] G Cantarella,et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.
[42] J. Tschopp,et al. Caspase‐induced inactivation of the anti‐apoptotic TRAF1 during Fas ligand‐mediated apoptosis , 2000, FEBS letters.
[43] M. Lenardo,et al. A crucial role for p80 TNF‐R2 in amplifying p60 TNF‐R1 apoptosis signals in T lymphocytes , 2000, European journal of immunology.
[44] F. Urano,et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.
[45] P. Freemont. Ubiquitination: RING for destruction? , 2000, Current Biology.
[46] A. Leonardi,et al. Physical and Functional Interaction of Filamin (Actin-binding Protein-280) and Tumor Necrosis Factor Receptor-associated Factor 2* , 2000, The Journal of Biological Chemistry.
[47] S. Lederman,et al. TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes. , 2000, Molecular immunology.
[48] H. Hanafusa,et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. , 1999, Molecular cell.
[49] D. Baltimore,et al. NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.
[50] B. Seed,et al. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. , 1999, Immunity.
[51] R. Beyaert,et al. TRAF1 is a TNF inducible regulator of NF‐κB activation , 1999 .
[52] D. Payan,et al. TNIK, a Novel Member of the Germinal Center Kinase Family That Activates the c-Jun N-terminal Kinase Pathway and Regulates the Cytoskeleton* , 1999, The Journal of Biological Chemistry.
[53] C. Hauser,et al. TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction* , 1999, The Journal of Biological Chemistry.
[54] Zhengbin Yao,et al. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1) , 1999, Oncogene.
[55] G. Cheng,et al. TANK Potentiates Tumor Necrosis Factor Receptor-Associated Factor-Mediated c-Jun N-Terminal Kinase/Stress-Activated Protein Kinase Activation through the Germinal Center Kinase Pathway , 1999, Molecular and Cellular Biology.
[56] Y. Lin,et al. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.
[57] J C Reed,et al. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.
[58] A. Leonardi,et al. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related. , 1999, Journal of immunology.
[59] E. Kieff,et al. The structural basis for the recognition of diverse receptor sequences by TRAF2. , 1999, Molecular cell.
[60] R. Paus,et al. Death deflected: IL‐15 inhibits TNF‐α‐mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL‐15Rα chain , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] C. Janeway,et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.
[62] T. Alber,et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. , 1999, Biochemistry.
[63] R. Ross,et al. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop , 1999, Nature Cell Biology.
[64] J. Holton,et al. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Baldwin,et al. Apoptosis Promotes a Caspase-induced Amino-terminal Truncation of IκBα That Functions as a Stable Inhibitor of NF-κB* , 1999, The Journal of Biological Chemistry.
[66] Peter Scheurich,et al. The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase* , 1999, The Journal of Biological Chemistry.
[67] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[68] G. Stark,et al. Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.
[69] R. Geha,et al. Structure of the murine TRAF1 gene. , 1999, Molecular immunology.
[70] M. Diaz-Meco,et al. The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.
[71] M. Karin,et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. , 1999, Genes & development.
[72] T. Serikawa,et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.
[73] K. Burns,et al. Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB. , 1999, The Biochemical journal.
[74] S. Morony,et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.
[75] Michael Karin,et al. Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .
[76] Hao Wu,et al. Structural basis for self-association and receptor recognition of human TRAF2 , 1999, Nature.
[77] B. Aggarwal,et al. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. , 1999, The Journal of biological chemistry.
[78] J. Ninomiya-Tsuji,et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.
[79] Guo-liang Yu,et al. Identification of a Novel Activation-inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand* , 1999, The Journal of Biological Chemistry.
[80] G. Bren,et al. Activation of IκB Kinase β by Protein Kinase C Isoforms , 1999, Molecular and Cellular Biology.
[81] P. Scheurich,et al. TNF receptor associated factors in cytokine signaling. , 1999, Cytokine & growth factor reviews.
[82] D. Wallach,et al. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .
[83] G. Khursigara,et al. Association of the p75 Neurotrophin Receptor with TRAF6* , 1999, The Journal of Biological Chemistry.
[84] E. Skolnik,et al. A Drosophila TNF-receptor-associated factor (TRAF) binds the Ste20 kinase Misshapen and activates Jun kinase , 1999, Current Biology.
[85] D. Goeddel,et al. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. , 1999, Science.
[86] H. Stein,et al. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. , 1999, Blood.
[87] A. Giordano,et al. Binding of CDK9 to TRAF2 , 1998, Journal of cellular biochemistry.
[88] P. Scheurich,et al. Identification of a TRAF (TNF Receptor-Associated Factor) Gene in Caenorhabditis elegans , 1998, Journal of Molecular Evolution.
[89] H. Engelmann,et al. CD40 induces resistance to TNF‐mediated apoptosis in a fibroblast cell line , 1998, European Journal of Immunology.
[90] R. Steinman,et al. The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor* , 1998, The Journal of Biological Chemistry.
[91] P. Scheurich,et al. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. , 1998, Journal of immunology.
[92] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[93] K. Miyazono,et al. ASK1 is essential for JNK/SAPK activation by TRAF2. , 1998, Molecular cell.
[94] J. Kyriakis,et al. Tumor Necrosis Factor Signaling to Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38 , 1998, The Journal of Biological Chemistry.
[95] B. Aggarwal,et al. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. , 1998, The Journal of biological chemistry.
[96] M. Kehry,et al. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. , 1998, Biochemistry.
[97] F. Martinon,et al. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 , 1998, Current Biology.
[98] V. Dixit,et al. RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.
[99] M. Boes,et al. The TNF receptor family member CD27 signals to Jun N‐terminal kinase via Traf‐2 , 1998, European journal of immunology.
[100] D. Ferrari,et al. Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.
[101] Crafford A. Harris,et al. Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.
[102] R. Gascoyne,et al. TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues. , 1998, The American journal of pathology.
[103] M. Kasahara,et al. The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28 , 1998, Immunological reviews.
[104] T. Mak,et al. CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand , 1998, The Journal of experimental medicine.
[105] F. Martinon,et al. MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.
[106] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[107] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[108] Takashi Uchiyama,et al. Activation of OX40 Signal Transduction Pathways Leads to Tumor Necrosis Factor Receptor-associated Factor (TRAF) 2- and TRAF5-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.
[109] Stefan Grimm,et al. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .
[110] D. Sassoon,et al. Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transduction pathway , 1998, Nature Genetics.
[111] H. Lodish,et al. Tumor Necrosis Factor Receptor (TNFR)-associated Factor 2A (TRAF2A), a TRAF2 Splice Variant with an Extended RING Finger Domain That Inhibits TNFR2-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.
[112] M. Mattei,et al. Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development , 1998, Mechanisms of Development.
[113] K. Okazaki,et al. Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) Stimulates Extracellular Signal–regulated Kinase (ERK) Activity in CD40 Signaling Along a Ras-independent Pathway , 1998, The Journal of experimental medicine.
[114] C. Thompson,et al. 4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB , 1998, Molecular and Cellular Biology.
[115] R. Steinman,et al. TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor , 1997, The Journal of experimental medicine.
[116] C. Ware,et al. Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-β Receptor* , 1997, The Journal of Biological Chemistry.
[117] Z. Cao,et al. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.
[118] John Calvin Reed,et al. The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.
[119] P. Feng,et al. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.
[120] H. Horvitz,et al. Phosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro * , 1997, The Journal of Biological Chemistry.
[121] R. Dubose,et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.
[122] C. Thompson,et al. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. , 1997, Genes & development.
[123] D. Goeddel,et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.
[124] D. Goeddel,et al. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[125] P. Scheurich,et al. Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. , 1997, Gene.
[126] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[127] T. Ayres,et al. Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1* , 1997, The Journal of Biological Chemistry.
[128] W. J. Boyle,et al. ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5* , 1997, The Journal of Biological Chemistry.
[129] T. Mak,et al. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. , 1997, Biochemical and biophysical research communications.
[130] Soo Young Lee,et al. TRAF-interacting Protein (TRIP): A Novel Component of the Tumor Necrosis Factor Receptor (TNFR)- and CD30-TRAF Signaling Complexes That Inhibits TRAF2-mediated NF-κB Activation , 1997, The Journal of experimental medicine.
[131] E. Kieff,et al. Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB , 1997 .
[132] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[133] Ko Okumura,et al. Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB Activation* , 1997, The Journal of Biological Chemistry.
[134] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[135] D. Goeddel,et al. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[136] Zhaodan Cao,et al. TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.
[137] J. Inoue,et al. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[138] D. Goeddel,et al. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[139] D. Vaux,et al. TRAF proteins and meprins share a conserved domain. , 1996, Trends in biochemical sciences.
[140] D. Goeddel,et al. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[141] C. Ware,et al. TRAF5, an Activator of NF-κB and Putative Signal Transducer for the Lymphotoxin-β Receptor* , 1996, The Journal of Biological Chemistry.
[142] D. Baltimore,et al. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. , 1996, Genes & development.
[143] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[144] Soo-Young Lee,et al. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors , 1996, The Journal of experimental medicine.
[145] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[146] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.
[147] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[148] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[149] P. Basset,et al. Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma (*) , 1995, The Journal of Biological Chemistry.
[150] D. Donner,et al. Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. , 1995, The Biochemical journal.
[151] M. Tewari,et al. Activation of the B-cell Surface Receptor CD40 Induces A20, a Novel Zinc Finger Protein That Inhibits Apoptosis (*) , 1995, The Journal of Biological Chemistry.
[152] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[153] C. Ware,et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.
[154] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.